Oligo counts were normalized by DESeq2 (12) and modeled as a negative binomial distribution to obtain estimates of variance in oligo counts across all samples. EmVars – defined as variants where one or more alleles altered GFP expression (emAlleles) – were determined for the plasmid controls and library replicates and tested for significant expression differences using a Wald’s test (6). A fold change (FC) difference of 1.5 between the plasmid controls and EBV library replicates and an FDR<0.05 were required for significance. EmVars were then assessed for allele-specific transactivation potential (allelic effects, AE) by comparing log2 ratios of the reference versus alternate alleles using a Student’s t-test (6). A FC=1.25 between the two alleles and an FDR<0.05 were required for significance. For the 320 multiallelic variants, the reference allele was compared to each alternate allele separately.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.